FCGR1A and neoplasm: A possible underlying mechanism that may explain the high GPS levels of patients with radiotherapy concerns inflammation or nutritional status, which is closely related to the signaling pathways of CD64/PI3k/Akt and MAPK/ERK signaling pathways induced by CRP and, stimulate tumor growth and worsen disease progression16,40.